BIOPLUS-INTERPHEX KOREA (BIX) 2025 returns to Seoul on October 15-17
February 25, 2025 | Tuesday | News
Exclusive networking opportunities, one-on-one partnering meetings, and industry-wide collaborations
The future of biopharmaceutical innovation will take centr- stage at BIOPLUS-INTERPHEX KOREA (BIX) 2025, returning on October 15-17, 2025, at Coex, Seoul. To explore the most recent developments influencing the future of healthcare, BIX 2025 will bring together experts, innovators, and thought leaders from around the world.
BIX has established itself as a must-attend event for professionals across the entire biopharmaceutical value chain. The exhibition and conference will feature innovations in biopharmaceutical development, manufacturing, and advanced biopharma technologies, giving participants unmatched access to the most recent market developments.
Spanning 30+ specialised conference sessions, BIX 2025 will serve as a platform for global experts to discuss key industry challenges and breakthroughs, covering everything from advanced drug delivery systems to state-of-the-art bioprocessing solutions. As the World’s Most Tangible Bio-healthcare Convention, BIX 2025 will bring together thought leaders and pioneers to showcase the latest advancements that are shaping the future of healthcare.
Following the success of BIX 2024, which welcomed 10,785 visitors, 232 companies, and 150 speakers from 15 countries, this year’s edition is set to elevate opportunities for both exhibitors and attendees.